- Home
- RCUS vs SHLS Comparison
RCUS vs SHLS Comparison
Compare RCUS & SHLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- SHLS
- Stock Information
- Founded
- RCUS 2015
- SHLS 1996
- Country
- RCUS United States
- SHLS United States
- Employees
- RCUS N/A
- SHLS N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- SHLS Semiconductors
- Sector
- RCUS Health Care
- SHLS Technology
- Exchange
- RCUS Nasdaq
- SHLS Nasdaq
- Market Cap
- RCUS 906.4M
- SHLS 790.0M
- IPO Year
- RCUS 2018
- SHLS 2021
- Fundamental
- Price
- RCUS $10.40
- SHLS $5.19
- Analyst Decision
- RCUS Buy
- SHLS Buy
- Analyst Count
- RCUS 8
- SHLS 22
- Target Price
- RCUS $20.71
- SHLS $9.34
- AVG Volume (30 Days)
- RCUS 783.0K
- SHLS 5.3M
- Earning Date
- RCUS 08-06-2025
- SHLS 08-05-2025
- Dividend Yield
- RCUS N/A
- SHLS N/A
- EPS Growth
- RCUS N/A
- SHLS N/A
- EPS
- RCUS N/A
- SHLS 0.12
- Revenue
- RCUS $262,000,000.00
- SHLS $400,354,000.00
- Revenue This Year
- RCUS N/A
- SHLS $11.49
- Revenue Next Year
- RCUS $28.73
- SHLS $11.71
- P/E Ratio
- RCUS N/A
- SHLS $43.45
- Revenue Growth
- RCUS 6.07
- SHLS N/A
- 52 Week Low
- RCUS $6.50
- SHLS $2.71
- 52 Week High
- RCUS $18.98
- SHLS $7.00
- Technical
- Relative Strength Index (RSI)
- RCUS 63.56
- SHLS 51.08
- Support Level
- RCUS $9.73
- SHLS $4.45
- Resistance Level
- RCUS $10.23
- SHLS $5.01
- Average True Range (ATR)
- RCUS 0.53
- SHLS 0.42
- MACD
- RCUS 0.07
- SHLS -0.04
- Stochastic Oscillator
- RCUS 82.11
- SHLS 52.60
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About SHLS Shoals Technologies Group Inc.
Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.